BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15728632)

  • 1. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.
    deSouza NM; O'Neill R; McIndoe GA; Dina R; Soutter WP
    AJR Am J Roentgenol; 2005 Mar; 184(3):999-1003. PubMed ID: 15728632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
    Lee EJ; Kim SH; Kim YH; Lee HJ
    Acta Radiol; 2011 May; 52(4):458-62. PubMed ID: 21498310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI appearances of borderline ovarian tumours.
    Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
    Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and MRI findings of sex cord-stromal tumor of the ovary.
    Jung SE; Rha SE; Lee JM; Park SY; Oh SN; Cho KS; Lee EJ; Byun JY; Hahn ST
    AJR Am J Roentgenol; 2005 Jul; 185(1):207-15. PubMed ID: 15972425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computerized tomography and MR tomography in diagnosis of ovarian tumors].
    Hamm B
    Radiologe; 1994 Jul; 34(7):362-9. PubMed ID: 7938483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis of computed tomography (CT) and magnetic resonance imaging (MRI) in evaluation of the extension of ovarian carcinoma].
    Mizuno K
    Rinsho Byori; 1992 Feb; 40(2):152-5. PubMed ID: 1583787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
    Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
    Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
    Park SY; Oh YT; Jung DC
    Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current update on borderline ovarian neoplasms.
    Lalwani N; Shanbhogue AK; Vikram R; Nagar A; Jagirdar J; Prasad SR
    AJR Am J Roentgenol; 2010 Feb; 194(2):330-6. PubMed ID: 20093592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.
    Grab D; Flock F; Stöhr I; Nüssle K; Rieber A; Fenchel S; Brambs HJ; Reske SN; Kreienberg R
    Gynecol Oncol; 2000 Jun; 77(3):454-9. PubMed ID: 10831359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ovarian Brenner tumor.
    Heye S; Bielen D; Vanbeckevoort D
    JBR-BTR; 2005; 88(5):245-6. PubMed ID: 16302335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cystadenofibroma with solid nodular components masqueraded as ovarian cancer.
    Shimizu S; Okano H; Ishitani K; Nomura H; Nishikawa T; Ohta H
    Arch Gynecol Obstet; 2009 May; 279(5):709-11. PubMed ID: 18779972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review.
    Bazot M; Daraï E; Nassar-Slaba J; Lafont C; Thomassin-Naggara I
    J Comput Assist Tomogr; 2008; 32(5):712-23. PubMed ID: 18830100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
    Berchuck A; Kohler MF; Hopkins MP; Humphrey PA; Robboy SJ; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC
    Gynecol Oncol; 1994 Feb; 52(2):232-6. PubMed ID: 7508877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent ovarian granulosa cell tumors: clinical and imaging features.
    Rha SE; Oh SN; Jung SE; Lee YJ; Lee AW; Byun JY
    Abdom Imaging; 2008; 33(1):119-25. PubMed ID: 17624570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
    Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB
    Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic features of ovarian borderline tumors with invasive implant.
    Ohta T; Ohmichi M; Hayasaka T; Saitoh M; Kojimahara T; Kawagoe J; Nakahara K; Motoyama T; Kurachi H
    Arch Gynecol Obstet; 2005 Oct; 272(4):278-82. PubMed ID: 16012777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
    Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
    Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.